ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 131 filers reported holding ARRAY BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $14,691,000 | +108.5% | 317,104 | +9.7% | 0.03% | +100.0% |
Q1 2019 | $7,045,000 | +76.8% | 288,951 | +3.3% | 0.01% | +55.6% |
Q4 2018 | $3,985,000 | +40.0% | 279,658 | +49.3% | 0.01% | +80.0% |
Q3 2018 | $2,846,000 | -15.6% | 187,256 | -6.8% | 0.01% | -28.6% |
Q2 2018 | $3,372,000 | +6.6% | 200,956 | +3.7% | 0.01% | 0.0% |
Q1 2018 | $3,162,000 | +28.1% | 193,778 | +0.5% | 0.01% | +40.0% |
Q4 2017 | $2,468,000 | -4.7% | 192,811 | -8.5% | 0.01% | -16.7% |
Q3 2017 | $2,591,000 | +50.8% | 210,685 | +2.6% | 0.01% | +50.0% |
Q2 2017 | $1,718,000 | -9.8% | 205,265 | -3.7% | 0.00% | 0.0% |
Q1 2017 | $1,905,000 | +7.5% | 213,082 | +5.7% | 0.00% | 0.0% |
Q4 2016 | $1,772,000 | +45.7% | 201,582 | +11.9% | 0.00% | +33.3% |
Q3 2016 | $1,216,000 | +89.1% | 180,210 | -0.2% | 0.00% | +50.0% |
Q2 2016 | $643,000 | +34.2% | 180,610 | +11.3% | 0.00% | +100.0% |
Q1 2016 | $479,000 | -27.9% | 162,207 | +3.0% | 0.00% | -50.0% |
Q4 2015 | $664,000 | +2.5% | 157,427 | +10.7% | 0.00% | 0.0% |
Q3 2015 | $648,000 | -34.1% | 142,192 | +4.2% | 0.00% | -33.3% |
Q2 2015 | $984,000 | -5.3% | 136,508 | -3.1% | 0.00% | 0.0% |
Q1 2015 | $1,039,000 | +79.8% | 140,923 | +15.4% | 0.00% | +50.0% |
Q4 2014 | $578,000 | +38.6% | 122,098 | +4.6% | 0.00% | +100.0% |
Q3 2014 | $417,000 | -21.6% | 116,773 | 0.0% | 0.00% | -50.0% |
Q2 2014 | $532,000 | +8.4% | 116,773 | +11.8% | 0.00% | +100.0% |
Q1 2014 | $491,000 | -10.4% | 104,440 | -4.6% | 0.00% | -50.0% |
Q4 2013 | $548,000 | -19.5% | 109,460 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $681,000 | +35.7% | 109,460 | -0.9% | 0.00% | 0.0% |
Q2 2013 | $502,000 | – | 110,495 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |